OptimisCorp.

Court of Chancery of Delaware·Decided August 26, 2015·No. CA 8773-VCP·Published

Opinion

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE

)

OPTIMISCORP, a Delaware ) corporation, ALAN MORELLI, and ) ANALOG VENTURES, LLC, )

)

Plaintiffs, ) C.A. No. 8773-VCP )

v. )

)

JOHN WAITE, WILLIAM ATKINS, ) GREGORY SMITH, and WILLIAM ) HORNE, )

)

Defendants. )

)

MEMORANDUM OPINION

Submitted: April 30, 2015 Decided: August 26, 2015

Anthony W. Clark, Esq., Douglas D. Herrmann, Esq., Amy C. Huffman, Esq., Danielle K. Berster, Esq., Ana Lucia Hurtado, Esq., SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP, Wilmington, Delaware; Darius Ogloza, Esq., OGLOZA FORTNEY LLP, San Francisco, California; Attorneys for Plaintiffs OptimisCorp, Alan Morelli, and Analog Ventures, LLC.

Stephen P. Brauerman, Esq., Vanessa R. Tiradentes, Esq., Sara E. Bussiere, Esq., BAYARD, P.A., Wilmington, Delaware; Attorneys for Defendants John Waite, William Atkins, and Gregory Smith.

Bruce E. Jameson, Esq., Eric J. Juray, Esq., John G. Day, Esq., PRICKETT, JONES & ELLIOTT, P.A., Wilmington, Delaware; Attorneys for Defendant William Horne.

PARSONS, Vice Chancellor.

On October 20, 2012, the board of the plaintiff corporation, a company involved in providing physical therapy services and developing physical therapy-related software, met and voted to terminate the plaintiff CEO upon the advice of several attorneys. Previously, another attorney, an independent third party, had conducted an investigation and concluded that the CEO had engaged in conduct—receiving oral sex from a subordinate employee in his office, which also was the bedroom of his house—that could amount to sexual harassment. The board, at the same meeting, also voted to amend a stockholders agreement to remove a provision that granted the initial stockholders, who were controlled by the CEO, the right to appoint a majority of the board. The CEO, a former corporate attorney, quickly moved to reacquire control, which included replacing every director he had appointed who had voted to remove him. Three of the four defendants also were directors of the plaintiff corporation and, as of the CEO‘s ouster, collectively held roughly as many shares as the CEO. The October 20 meeting was a bungled act of corporate governance marred by several flaws. Based on those missteps, the CEO eventually prevailed in having his removal and the amendment to the stockholders agreement vacated in a subsequent action in this Court pursuant to 8 Del. C. § 225.

Back at the helm, the CEO soon terminated the fourth defendant in this action, the company‘s CFO, who was involved romantically with the CEO‘s former wife. A few months later, the three director defendants resigned from the company‘s board and the next day sued the company in California, where it is headquartered, to rescind the stock- for-stock transaction by which their former physical therapy company had become a

subsidiary of the plaintiff corporation. The director defendants were terminated from that company shortly thereafter.

In this action, the CEO and the company return to this Court alleging that the four defendants engaged in a long-running and wide-ranging conspiracy that involved, essentially, everyone who disagreed with the CEO‘s management of the company. The plaintiffs seek approximately $50 million in damages, as well as equitable relief in the form of an extension of the stockholders agreement in order to cement the CEO‘s control for another two years. The alleged wrongs range from nebulous breaches of fiduciary duty based on undermining the company‘s strategic vision to breach of contract claims. After extensive pre-trial proceedings, I tried this matter for six days in February 2015. This Memorandum Opinion (―Opinion‖) reflects my post-trial findings of fact and conclusions of law, as well as my rulings on certain ancillary motions. Because of the far-ranging claims advanced by the plaintiffs and the number of non-party actors who figure in their narrative, the recitation of the facts is unusually lengthy.

Overall, the plaintiffs seek damages and equitable relief for breach of the duty of loyalty, breach of contract, and tortious interference, and they advance secondary liability theories of aiding and abetting and conspiracy. The defendants deny liability on all counts, argue that there was and is no conspiracy, and contend that the CEO is a paranoid narcissist. The defendants also accuse the plaintiffs of having undermined the integrity of the litigation process by engaging in conduct akin to bribing and tampering with witnesses.

For the reasons that follow, I conclude that the plaintiffs‘ actions have threatened the integrity of this proceeding. The record includes evidence that supports a finding that the plaintiffs paid witnesses for the content of their testimony, threatened witnesses with criminal charges, attempted to open criminal investigations, and generally engaged in threats of civil litigation based on questionable or baseless claims, all in an effort to secure ―evidence‖ that would aid the plaintiffs in this case. As sanctions for this conduct, I dismiss the plaintiffs‘ conspiracy claims against all of the defendants (although I also hold, in the alternative, that the plaintiffs failed to prove their conspiracy claim) and I draw certain adverse inferences against the plaintiffs in connection with certain of their other claims. Additionally, I find that the plaintiffs have not met their burden of proving: (1) their breach of the duty of loyalty claims, with the exception of one claim relating to candor; (2) their claims for breach of either the terms of the stockholders agreement or the implied covenant of good faith and fair dealing inherent in that agreement; or (3) their tortious interference claims. Finally, I find that the plaintiffs have not proven damages.

I. INTEGRITY OF THE PROCEEDINGS Unfortunately, because it bears on witness credibility and, ultimately, the facts found in this Opinion, I consider it necessary to start in the middle of this story and address the defendants‘ charge that the plaintiffs have undermined the integrity of these proceedings, and only then tell the facts from the beginning.1 After a truncated recitation

1 Citations to testimony presented at trial are in the form ―Tr. # (X)‖ with ―X‖ representing the surname of the speaker, if not clear from the text. Exhibits will be cited as ―JX #‖ and facts drawn from the parties‘ pre-trial Joint Stipulation are

of the necessary background, all of which is explored in greater detail in Section II infra, I turn to the acts that the defendants argue were wrongful.

A. Relevant Actors

There are three Plaintiffs in this action. Plaintiff OptimisCorp (―Optimis‖ or the ―Company‖) is a Delaware corporation with its principal place of business in Pacific Palisades, California. Plaintiff Alan Morelli has been the Company‘s CEO since its inception, with the exception of the period from October 20, 2012 through March 21, 2013, during which time his status was uncertain. Plaintiff Analog Ventures, LLC (―Analog‖), is a California LLC managed by Morelli that holds many of his Optimis shares.2 When this action was filed, Morelli owned or controlled at least 7,400,000 shares of Optimis stock.3 Morelli, who is described in detail in Section II.D infra, is the locomotive propelling this litigation. Described as a charismatic visionary, Morelli succeeded in convincing numerous successful business owners, including the three director defendants,

cited as ―JS § #.‖ Because of the sheer quantity of the evidence, I note that the record citations provided often are indicative, rather than exhaustive, and are provided only for facts that may be disputed.

Free access — add to your briefcase to read the full text and ask questions with AI

OptimisCorp., (Del. Ct. App. 2015).

OptimisCorp. (OptimisCorp.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. James L. Blaszak
349 F.3d 881 (Sixth Circuit, 2003)
Stearn v. Koch
628 A.2d 44 (Supreme Court of Delaware, 1993)
Dunlap v. State Farm Fire & Casualty Co.
878 A.2d 434 (Supreme Court of Delaware, 2005)
Black v. Hollinger International Inc.
872 A.2d 559 (Supreme Court of Delaware, 2005)
Malpiede v. Townson
780 A.2d 1075 (Supreme Court of Delaware, 2001)
NACCO INDUSTRIES, INC. v. Applica Inc.
997 A.2d 1 (Court of Chancery of Delaware, 2009)
Parfi Holding AB v. Mirror Image Internet, Inc.
817 A.2d 149 (Supreme Court of Delaware, 2002)
Beard Research, Inc. v. Kates
981 A.2d 1175 (Court of Chancery of Delaware, 2009)
Parfi Holding AB v. Mirror Image Internet, Inc.
794 A.2d 1211 (Court of Chancery of Delaware, 2001)
Shearin v. E.F. Hutton Group, Inc.
652 A.2d 578 (Court of Chancery of Delaware, 1994)
Mendel v. Carroll
651 A.2d 297 (Court of Chancery of Delaware, 1994)
Parfi Holding AB v. Mirror Image Internet, Inc.
954 A.2d 911 (Court of Chancery of Delaware, 2008)
In Re Transkaryotic Therapies, Inc.
954 A.2d 346 (Court of Chancery of Delaware, 2008)
Weber v. State
457 A.2d 674 (Supreme Court of Delaware, 1983)
McMullin v. Beran
765 A.2d 910 (Supreme Court of Delaware, 2000)
Hollinger International, Inc. v. Black
844 A.2d 1022 (Court of Chancery of Delaware, 2004)
Unocal Corp. v. Mesa Petroleum Co.
493 A.2d 946 (Supreme Court of Delaware, 1985)
HMG/Courtland Properties, Inc. v. Gray
749 A.2d 94 (Court of Chancery of Delaware, 1999)